nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Icatibant—BDKRB2—epilepsy syndrome	0.0113	0.878	CrCbGaD
Goserelin—GNRHR—hindbrain—epilepsy syndrome	0.0101	0.334	CbGeAlD
Goserelin—GNRHR—brainstem—epilepsy syndrome	0.00577	0.192	CbGeAlD
Goserelin—GNRHR—head—epilepsy syndrome	0.00319	0.106	CbGeAlD
Goserelin—GNRHR—nervous system—epilepsy syndrome	0.00302	0.1	CbGeAlD
Goserelin—GNRHR—central nervous system—epilepsy syndrome	0.00291	0.0967	CbGeAlD
Goserelin—GNRHR—cerebellum—epilepsy syndrome	0.00284	0.0945	CbGeAlD
Goserelin—GNRHR—brain—epilepsy syndrome	0.00231	0.0767	CbGeAlD
Goserelin—Pentagastrin—BCHE—epilepsy syndrome	0.00156	0.122	CrCbGaD
Goserelin—LHCGR—GPCR ligand binding—CCL2—epilepsy syndrome	0.000211	0.000649	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNAO1—epilepsy syndrome	0.00021	0.000646	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—OPRD1—epilepsy syndrome	0.00021	0.000646	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR10—epilepsy syndrome	0.000209	0.000644	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000207	0.000638	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000206	0.000635	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000206	0.000635	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000204	0.00063	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000203	0.000626	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CNR1—epilepsy syndrome	0.000202	0.000624	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000202	0.000621	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000201	0.00062	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDYN—epilepsy syndrome	0.000201	0.00062	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CHRM1—epilepsy syndrome	0.000201	0.00062	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR7—epilepsy syndrome	0.000201	0.00062	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GRM1—epilepsy syndrome	0.000201	0.00062	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000199	0.000614	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000199	0.000614	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000199	0.000614	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HTR7—epilepsy syndrome	0.000197	0.000608	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000194	0.000597	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000192	0.000591	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR3—epilepsy syndrome	0.00019	0.000586	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000189	0.000583	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000189	0.000583	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GFAP—epilepsy syndrome	0.000189	0.000582	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GAL—epilepsy syndrome	0.000189	0.000582	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT3—epilepsy syndrome	0.000188	0.00058	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GRM5—epilepsy syndrome	0.000187	0.000576	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASP2—epilepsy syndrome	0.000187	0.000576	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CHRM3—epilepsy syndrome	0.000187	0.000576	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HRH3—epilepsy syndrome	0.000186	0.000572	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—NPY—epilepsy syndrome	0.000185	0.000571	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000185	0.00057	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR5—epilepsy syndrome	0.000184	0.000568	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AVP—epilepsy syndrome	0.000183	0.000564	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000183	0.000563	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GRM2—epilepsy syndrome	0.000183	0.000563	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—HTR2A—epilepsy syndrome	0.00018	0.000556	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000179	0.000552	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—OXT—epilepsy syndrome	0.000179	0.000551	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CRH—epilepsy syndrome	0.000179	0.000551	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000179	0.000551	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CHRM2—epilepsy syndrome	0.000176	0.000542	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000176	0.000542	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000176	0.000542	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR3—epilepsy syndrome	0.000173	0.000532	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CDC42—epilepsy syndrome	0.000172	0.000529	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—AGT—epilepsy syndrome	0.000171	0.000527	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GABBR1—epilepsy syndrome	0.000171	0.000527	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NPY—epilepsy syndrome	0.000168	0.000518	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AVP—epilepsy syndrome	0.000166	0.000512	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SSTR3—epilepsy syndrome	0.000165	0.000509	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HRH3—epilepsy syndrome	0.000164	0.000505	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—OXT—epilepsy syndrome	0.000162	0.0005	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CRH—epilepsy syndrome	0.000162	0.0005	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000162	0.0005	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL3—epilepsy syndrome	0.000162	0.0005	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000162	0.000498	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—SST—epilepsy syndrome	0.000162	0.000498	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000162	0.000498	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—OPRM1—epilepsy syndrome	0.000161	0.000497	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000158	0.000488	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SSTR1—epilepsy syndrome	0.000158	0.000488	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR8—epilepsy syndrome	0.000158	0.000488	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NPY2R—epilepsy syndrome	0.000158	0.000488	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR9—epilepsy syndrome	0.000158	0.000488	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000158	0.000488	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000156	0.00048	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GRM4—epilepsy syndrome	0.000155	0.000478	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GRM3—epilepsy syndrome	0.000155	0.000478	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DUSP4—epilepsy syndrome	0.000152	0.00047	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR3—epilepsy syndrome	0.000152	0.00047	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SSTR2—epilepsy syndrome	0.000152	0.00047	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000152	0.000469	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000152	0.000468	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000152	0.000468	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000149	0.00046	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000149	0.000458	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NPY—epilepsy syndrome	0.000148	0.000458	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000148	0.000458	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GRM8—epilepsy syndrome	0.000147	0.000453	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PGF—epilepsy syndrome	0.000147	0.000453	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SST—epilepsy syndrome	0.000147	0.000452	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR2—epilepsy syndrome	0.000147	0.000452	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000146	0.000449	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AGT—epilepsy syndrome	0.000144	0.000445	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—POMC—epilepsy syndrome	0.000144	0.000444	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000144	0.000443	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL3—epilepsy syndrome	0.000143	0.000441	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CRH—epilepsy syndrome	0.000143	0.000441	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HSPB1—epilepsy syndrome	0.000143	0.000441	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL2—epilepsy syndrome	0.000143	0.000441	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—OXT—epilepsy syndrome	0.000143	0.000441	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR5—epilepsy syndrome	0.000141	0.000435	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL2—epilepsy syndrome	0.000141	0.000434	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—OPRD1—epilepsy syndrome	0.00014	0.000433	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNAO1—epilepsy syndrome	0.00014	0.000433	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000139	0.000427	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000138	0.000426	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000138	0.000425	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000138	0.000425	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CNR1—epilepsy syndrome	0.000135	0.000418	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000135	0.000416	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CHRM1—epilepsy syndrome	0.000135	0.000415	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GRM1—epilepsy syndrome	0.000135	0.000415	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR7—epilepsy syndrome	0.000135	0.000415	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDYN—epilepsy syndrome	0.000135	0.000415	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000133	0.000411	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TSC1—epilepsy syndrome	0.000133	0.00041	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTK2B—epilepsy syndrome	0.000133	0.00041	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HTR7—epilepsy syndrome	0.000132	0.000407	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AGT—epilepsy syndrome	0.000131	0.000404	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NTRK2—epilepsy syndrome	0.00013	0.000399	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR2—epilepsy syndrome	0.00013	0.000399	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SST—epilepsy syndrome	0.00013	0.000399	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DUSP6—epilepsy syndrome	0.000128	0.000396	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000128	0.000395	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000127	0.000391	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000127	0.00039	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GFAP—epilepsy syndrome	0.000127	0.00039	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GAL—epilepsy syndrome	0.000127	0.00039	CbGpPWpGaD
Goserelin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000126	0.0002	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PLAT—epilepsy syndrome	0.000126	0.000389	CbGpPWpGaD
Goserelin—Vision blurred—Gabapentin—epilepsy syndrome	0.000126	0.000199	CcSEcCtD
Goserelin—Headache—Vigabatrin—epilepsy syndrome	0.000126	0.000199	CcSEcCtD
Goserelin—Hypertension—Pregabalin—epilepsy syndrome	0.000126	0.000199	CcSEcCtD
Goserelin—Vomiting—Diazepam—epilepsy syndrome	0.000126	0.000199	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AKT3—epilepsy syndrome	0.000126	0.000388	CbGpPWpGaD
Goserelin—Anorexia—Valproic Acid—epilepsy syndrome	0.000126	0.000199	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GRM5—epilepsy syndrome	0.000125	0.000386	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CHRM3—epilepsy syndrome	0.000125	0.000386	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP2—epilepsy syndrome	0.000125	0.000386	CbGpPWpGaD
Goserelin—Rash—Diazepam—epilepsy syndrome	0.000125	0.000198	CcSEcCtD
Goserelin—Dermatitis—Diazepam—epilepsy syndrome	0.000125	0.000197	CcSEcCtD
Goserelin—Arthralgia—Pregabalin—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Myalgia—Pregabalin—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Chest pain—Pregabalin—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Dizziness—Zonisamide—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Headache—Diazepam—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Anxiety—Pregabalin—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Anaemia—Gabapentin—epilepsy syndrome	0.000124	0.000196	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000123	0.000195	CcSEcCtD
Goserelin—Hypotension—Valproic Acid—epilepsy syndrome	0.000123	0.000195	CcSEcCtD
Goserelin—Asthenia—Carbamazepine—epilepsy syndrome	0.000123	0.000195	CcSEcCtD
Goserelin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000123	0.000194	CcSEcCtD
Goserelin—Discomfort—Pregabalin—epilepsy syndrome	0.000123	0.000194	CcSEcCtD
Goserelin—Nausea—Fosphenytoin—epilepsy syndrome	0.000123	0.000194	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—AVP—epilepsy syndrome	0.000123	0.000378	CbGpPWpGaD
Goserelin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000122	0.000193	CcSEcCtD
Goserelin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000122	0.000193	CcSEcCtD
Goserelin—Vomiting—Felbamate—epilepsy syndrome	0.000122	0.000193	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000122	0.000375	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL12—epilepsy syndrome	0.000122	0.000375	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—POMC—epilepsy syndrome	0.000122	0.000375	CbGpPWpGaD
Goserelin—Dry mouth—Pregabalin—epilepsy syndrome	0.000122	0.000192	CcSEcCtD
Goserelin—Pruritus—Carbamazepine—epilepsy syndrome	0.000121	0.000192	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000121	0.000374	CbGpPWpGaD
Goserelin—Rash—Felbamate—epilepsy syndrome	0.000121	0.000191	CcSEcCtD
Goserelin—Eye disorder—Topiramate—epilepsy syndrome	0.000121	0.000191	CcSEcCtD
Goserelin—Dermatitis—Felbamate—epilepsy syndrome	0.000121	0.000191	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000121	0.000372	CbGpPWpGaD
Goserelin—Malaise—Gabapentin—epilepsy syndrome	0.000121	0.000191	CcSEcCtD
Goserelin—Headache—Felbamate—epilepsy syndrome	0.00012	0.00019	CcSEcCtD
Goserelin—Confusional state—Pregabalin—epilepsy syndrome	0.00012	0.00019	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.00012	0.00019	CcSEcCtD
Goserelin—Cardiac disorder—Topiramate—epilepsy syndrome	0.00012	0.00019	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CX3CR1—epilepsy syndrome	0.00012	0.00037	CbGpPWpGaD
Goserelin—Leukopenia—Gabapentin—epilepsy syndrome	0.00012	0.000189	CcSEcCtD
Goserelin—Dizziness—Clonazepam—epilepsy syndrome	0.00012	0.000189	CcSEcCtD
Goserelin—Nausea—Vigabatrin—epilepsy syndrome	0.00012	0.000189	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—JUNB—epilepsy syndrome	0.00012	0.000368	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CNR1—epilepsy syndrome	0.00012	0.000368	CbGpPWpGaD
Goserelin—Vomiting—Zonisamide—epilepsy syndrome	0.000119	0.000189	CcSEcCtD
Goserelin—Insomnia—Valproic Acid—epilepsy syndrome	0.000119	0.000188	CcSEcCtD
Goserelin—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000119	0.000188	CcSEcCtD
Goserelin—Oedema—Pregabalin—epilepsy syndrome	0.000119	0.000188	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PLCB1—epilepsy syndrome	0.000119	0.000367	CbGpPWpGaD
Goserelin—Asthenia—Lamotrigine—epilepsy syndrome	0.000119	0.000188	CcSEcCtD
Goserelin—Dizziness—Phenytoin—epilepsy syndrome	0.000119	0.000188	CcSEcCtD
Goserelin—Rash—Zonisamide—epilepsy syndrome	0.000118	0.000187	CcSEcCtD
Goserelin—Infection—Pregabalin—epilepsy syndrome	0.000118	0.000187	CcSEcCtD
Goserelin—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000118	0.000187	CcSEcCtD
Goserelin—Palpitations—Gabapentin—epilepsy syndrome	0.000118	0.000187	CcSEcCtD
Goserelin—Dermatitis—Zonisamide—epilepsy syndrome	0.000118	0.000187	CcSEcCtD
Goserelin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000118	0.000187	CcSEcCtD
Goserelin—Nausea—Diazepam—epilepsy syndrome	0.000118	0.000186	CcSEcCtD
Goserelin—Headache—Zonisamide—epilepsy syndrome	0.000118	0.000186	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000118	0.000363	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000118	0.000363	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CHRM2—epilepsy syndrome	0.000118	0.000363	CbGpPWpGaD
Goserelin—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000118	0.000186	CcSEcCtD
Goserelin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000117	0.000186	CcSEcCtD
Goserelin—Angiopathy—Topiramate—epilepsy syndrome	0.000117	0.000186	CcSEcCtD
Goserelin—Pruritus—Lamotrigine—epilepsy syndrome	0.000117	0.000186	CcSEcCtD
Goserelin—Shock—Pregabalin—epilepsy syndrome	0.000117	0.000185	CcSEcCtD
Goserelin—Somnolence—Valproic Acid—epilepsy syndrome	0.000117	0.000185	CcSEcCtD
Goserelin—Immune system disorder—Topiramate—epilepsy syndrome	0.000117	0.000185	CcSEcCtD
Goserelin—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000117	0.000185	CcSEcCtD
Goserelin—Cough—Gabapentin—epilepsy syndrome	0.000117	0.000185	CcSEcCtD
Goserelin—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000117	0.000184	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HTR7—epilepsy syndrome	0.000117	0.000359	CbGpPWpGaD
Goserelin—Tachycardia—Pregabalin—epilepsy syndrome	0.000116	0.000184	CcSEcCtD
Goserelin—Chills—Topiramate—epilepsy syndrome	0.000116	0.000184	CcSEcCtD
Goserelin—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000116	0.000183	CcSEcCtD
Goserelin—Convulsion—Gabapentin—epilepsy syndrome	0.000116	0.000183	CcSEcCtD
Goserelin—Skin disorder—Pregabalin—epilepsy syndrome	0.000116	0.000183	CcSEcCtD
Goserelin—Hypertension—Gabapentin—epilepsy syndrome	0.000116	0.000183	CcSEcCtD
Goserelin—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000115	0.000182	CcSEcCtD
Goserelin—Vomiting—Clonazepam—epilepsy syndrome	0.000115	0.000182	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CDC42—epilepsy syndrome	0.000115	0.000354	CbGpPWpGaD
Goserelin—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000115	0.000181	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GABBR1—epilepsy syndrome	0.000114	0.000353	CbGpPWpGaD
Goserelin—Alopecia—Topiramate—epilepsy syndrome	0.000114	0.000181	CcSEcCtD
Goserelin—Vomiting—Phenytoin—epilepsy syndrome	0.000114	0.000181	CcSEcCtD
Goserelin—Rash—Clonazepam—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Dermatitis—Clonazepam—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Arthralgia—Gabapentin—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Chest pain—Gabapentin—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Myalgia—Gabapentin—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Nausea—Felbamate—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Fatigue—Valproic Acid—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Anxiety—Gabapentin—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Anorexia—Pregabalin—epilepsy syndrome	0.000114	0.00018	CcSEcCtD
Goserelin—Dizziness—Carbamazepine—epilepsy syndrome	0.000113	0.000179	CcSEcCtD
Goserelin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000113	0.000179	CcSEcCtD
Goserelin—Headache—Clonazepam—epilepsy syndrome	0.000113	0.000179	CcSEcCtD
Goserelin—Rash—Phenytoin—epilepsy syndrome	0.000113	0.000179	CcSEcCtD
Goserelin—Mental disorder—Topiramate—epilepsy syndrome	0.000113	0.000179	CcSEcCtD
Goserelin—Dermatitis—Phenytoin—epilepsy syndrome	0.000113	0.000179	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HBEGF—epilepsy syndrome	0.000113	0.000349	CbGpPWpGaD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000113	0.000179	CcSEcCtD
Goserelin—Rash—Oxcarbazepine—epilepsy syndrome	0.000113	0.000178	CcSEcCtD
Goserelin—Constipation—Valproic Acid—epilepsy syndrome	0.000113	0.000178	CcSEcCtD
Goserelin—Pain—Valproic Acid—epilepsy syndrome	0.000113	0.000178	CcSEcCtD
Goserelin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000113	0.000178	CcSEcCtD
Goserelin—Headache—Phenytoin—epilepsy syndrome	0.000113	0.000178	CcSEcCtD
Goserelin—Malnutrition—Topiramate—epilepsy syndrome	0.000113	0.000178	CcSEcCtD
Goserelin—Erythema—Topiramate—epilepsy syndrome	0.000113	0.000178	CcSEcCtD
Goserelin—Discomfort—Gabapentin—epilepsy syndrome	0.000113	0.000178	CcSEcCtD
Goserelin—Headache—Oxcarbazepine—epilepsy syndrome	0.000112	0.000177	CcSEcCtD
Goserelin—Nausea—Zonisamide—epilepsy syndrome	0.000112	0.000176	CcSEcCtD
Goserelin—Dry mouth—Gabapentin—epilepsy syndrome	0.000111	0.000176	CcSEcCtD
Goserelin—Hypotension—Pregabalin—epilepsy syndrome	0.000111	0.000176	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AVP—epilepsy syndrome	0.000111	0.000343	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT3—epilepsy syndrome	0.000111	0.000343	CbGpPWpGaD
Goserelin—Flatulence—Topiramate—epilepsy syndrome	0.000111	0.000175	CcSEcCtD
Goserelin—Tension—Topiramate—epilepsy syndrome	0.000111	0.000175	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—POMC—epilepsy syndrome	0.00011	0.00034	CbGpPWpGaD
Goserelin—Confusional state—Gabapentin—epilepsy syndrome	0.00011	0.000174	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HRH3—epilepsy syndrome	0.00011	0.000338	CbGpPWpGaD
Goserelin—Dizziness—Lamotrigine—epilepsy syndrome	0.00011	0.000173	CcSEcCtD
Goserelin—Nervousness—Topiramate—epilepsy syndrome	0.000109	0.000173	CcSEcCtD
Goserelin—Oedema—Gabapentin—epilepsy syndrome	0.000109	0.000173	CcSEcCtD
Goserelin—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000109	0.000173	CcSEcCtD
Goserelin—Vomiting—Carbamazepine—epilepsy syndrome	0.000109	0.000173	CcSEcCtD
Goserelin—Back pain—Topiramate—epilepsy syndrome	0.000109	0.000172	CcSEcCtD
Goserelin—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000109	0.000172	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000109	0.000172	CcSEcCtD
Goserelin—Infection—Gabapentin—epilepsy syndrome	0.000109	0.000172	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADAM10—epilepsy syndrome	0.000109	0.000335	CbGpPWpGaD
Goserelin—Muscle spasms—Topiramate—epilepsy syndrome	0.000108	0.000171	CcSEcCtD
Goserelin—Rash—Carbamazepine—epilepsy syndrome	0.000108	0.000171	CcSEcCtD
Goserelin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000108	0.000171	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCL2—epilepsy syndrome	0.000108	0.000333	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—OPRM1—epilepsy syndrome	0.000108	0.000333	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000108	0.00017	CcSEcCtD
Goserelin—Insomnia—Pregabalin—epilepsy syndrome	0.000108	0.00017	CcSEcCtD
Goserelin—Nausea—Clonazepam—epilepsy syndrome	0.000108	0.00017	CcSEcCtD
Goserelin—Headache—Carbamazepine—epilepsy syndrome	0.000108	0.00017	CcSEcCtD
Goserelin—Shock—Gabapentin—epilepsy syndrome	0.000108	0.00017	CcSEcCtD
Goserelin—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000107	0.000169	CcSEcCtD
Goserelin—Paraesthesia—Pregabalin—epilepsy syndrome	0.000107	0.000169	CcSEcCtD
Goserelin—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000107	0.000169	CcSEcCtD
Goserelin—Nausea—Phenytoin—epilepsy syndrome	0.000107	0.000169	CcSEcCtD
Goserelin—Tachycardia—Gabapentin—epilepsy syndrome	0.000107	0.000169	CcSEcCtD
Goserelin—Dyspnoea—Pregabalin—epilepsy syndrome	0.000106	0.000168	CcSEcCtD
Goserelin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000106	0.000168	CcSEcCtD
Goserelin—Vision blurred—Topiramate—epilepsy syndrome	0.000106	0.000168	CcSEcCtD
Goserelin—Skin disorder—Gabapentin—epilepsy syndrome	0.000106	0.000168	CcSEcCtD
Goserelin—Somnolence—Pregabalin—epilepsy syndrome	0.000106	0.000167	CcSEcCtD
Goserelin—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000106	0.000167	CcSEcCtD
Goserelin—Vomiting—Lamotrigine—epilepsy syndrome	0.000105	0.000167	CcSEcCtD
Goserelin—Urticaria—Valproic Acid—epilepsy syndrome	0.000105	0.000166	CcSEcCtD
Goserelin—Rash—Lamotrigine—epilepsy syndrome	0.000105	0.000165	CcSEcCtD
Goserelin—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000105	0.000165	CcSEcCtD
Goserelin—Dermatitis—Lamotrigine—epilepsy syndrome	0.000104	0.000165	CcSEcCtD
Goserelin—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000104	0.000165	CcSEcCtD
Goserelin—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000104	0.000165	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000104	0.000321	CbGpPWpGaD
Goserelin—Anorexia—Gabapentin—epilepsy syndrome	0.000104	0.000165	CcSEcCtD
Goserelin—Anaemia—Topiramate—epilepsy syndrome	0.000104	0.000165	CcSEcCtD
Goserelin—Headache—Lamotrigine—epilepsy syndrome	0.000104	0.000164	CcSEcCtD
Goserelin—Decreased appetite—Pregabalin—epilepsy syndrome	0.000104	0.000164	CcSEcCtD
Goserelin—Fatigue—Pregabalin—epilepsy syndrome	0.000103	0.000162	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—S100B—epilepsy syndrome	0.000103	0.000316	CbGpPWpGaD
Goserelin—Hypotension—Gabapentin—epilepsy syndrome	0.000102	0.000161	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR3—epilepsy syndrome	0.000102	0.000314	CbGpPWpGaD
Goserelin—Nausea—Carbamazepine—epilepsy syndrome	0.000102	0.000161	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000102	0.000314	CbGpPWpGaD
Goserelin—Pain—Pregabalin—epilepsy syndrome	0.000102	0.000161	CcSEcCtD
Goserelin—Constipation—Pregabalin—epilepsy syndrome	0.000102	0.000161	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SOCS3—epilepsy syndrome	0.000102	0.000313	CbGpPWpGaD
Goserelin—Malaise—Topiramate—epilepsy syndrome	0.000102	0.000161	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CDC42—epilepsy syndrome	0.000101	0.000313	CbGpPWpGaD
Goserelin—Leukopenia—Topiramate—epilepsy syndrome	0.000101	0.000159	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	9.96e-05	0.000157	CcSEcCtD
Goserelin—Palpitations—Topiramate—epilepsy syndrome	9.95e-05	0.000157	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ATP2A2—epilepsy syndrome	9.94e-05	0.000306	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NPY—epilepsy syndrome	9.94e-05	0.000306	CbGpPWpGaD
Goserelin—Insomnia—Gabapentin—epilepsy syndrome	9.88e-05	0.000156	CcSEcCtD
Goserelin—Nausea—Lamotrigine—epilepsy syndrome	9.85e-05	0.000156	CcSEcCtD
Goserelin—Cough—Topiramate—epilepsy syndrome	9.83e-05	0.000155	CcSEcCtD
Goserelin—Feeling abnormal—Pregabalin—epilepsy syndrome	9.82e-05	0.000155	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—AVP—epilepsy syndrome	9.82e-05	0.000303	CbGpPWpGaD
Goserelin—Paraesthesia—Gabapentin—epilepsy syndrome	9.81e-05	0.000155	CcSEcCtD
Goserelin—Convulsion—Topiramate—epilepsy syndrome	9.76e-05	0.000154	CcSEcCtD
Goserelin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	9.74e-05	0.000154	CcSEcCtD
Goserelin—Dyspnoea—Gabapentin—epilepsy syndrome	9.74e-05	0.000154	CcSEcCtD
Goserelin—Hypertension—Topiramate—epilepsy syndrome	9.72e-05	0.000154	CcSEcCtD
Goserelin—Somnolence—Gabapentin—epilepsy syndrome	9.71e-05	0.000154	CcSEcCtD
Goserelin—Hypersensitivity—Valproic Acid—epilepsy syndrome	9.71e-05	0.000154	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—AGT—epilepsy syndrome	9.67e-05	0.000298	CbGpPWpGaD
Goserelin—Dyspepsia—Gabapentin—epilepsy syndrome	9.62e-05	0.000152	CcSEcCtD
Goserelin—Myalgia—Topiramate—epilepsy syndrome	9.59e-05	0.000152	CcSEcCtD
Goserelin—Chest pain—Topiramate—epilepsy syndrome	9.59e-05	0.000152	CcSEcCtD
Goserelin—Arthralgia—Topiramate—epilepsy syndrome	9.59e-05	0.000152	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HSPB1—epilepsy syndrome	9.59e-05	0.000296	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL3—epilepsy syndrome	9.59e-05	0.000296	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—OXT—epilepsy syndrome	9.59e-05	0.000296	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL2—epilepsy syndrome	9.59e-05	0.000296	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CRH—epilepsy syndrome	9.59e-05	0.000296	CbGpPWpGaD
Goserelin—Anxiety—Topiramate—epilepsy syndrome	9.56e-05	0.000151	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	9.52e-05	0.000151	CcSEcCtD
Goserelin—Decreased appetite—Gabapentin—epilepsy syndrome	9.5e-05	0.00015	CcSEcCtD
Goserelin—Discomfort—Topiramate—epilepsy syndrome	9.47e-05	0.00015	CcSEcCtD
Goserelin—Urticaria—Pregabalin—epilepsy syndrome	9.47e-05	0.00015	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCR5—epilepsy syndrome	9.46e-05	0.000292	CbGpPWpGaD
Goserelin—Asthenia—Valproic Acid—epilepsy syndrome	9.46e-05	0.000149	CcSEcCtD
Goserelin—Fatigue—Gabapentin—epilepsy syndrome	9.42e-05	0.000149	CcSEcCtD
Goserelin—Abdominal pain—Pregabalin—epilepsy syndrome	9.42e-05	0.000149	CcSEcCtD
Goserelin—Body temperature increased—Pregabalin—epilepsy syndrome	9.42e-05	0.000149	CcSEcCtD
Goserelin—Dry mouth—Topiramate—epilepsy syndrome	9.38e-05	0.000148	CcSEcCtD
Goserelin—Constipation—Gabapentin—epilepsy syndrome	9.34e-05	0.000148	CcSEcCtD
Goserelin—Pain—Gabapentin—epilepsy syndrome	9.34e-05	0.000148	CcSEcCtD
Goserelin—Pruritus—Valproic Acid—epilepsy syndrome	9.33e-05	0.000147	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HES1—epilepsy syndrome	9.28e-05	0.000286	CbGpPWpGaD
Goserelin—Confusional state—Topiramate—epilepsy syndrome	9.27e-05	0.000147	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—HTR2A—epilepsy syndrome	9.26e-05	0.000285	CbGpPWpGaD
Goserelin—Oedema—Topiramate—epilepsy syndrome	9.19e-05	0.000145	CcSEcCtD
Goserelin—Infection—Topiramate—epilepsy syndrome	9.13e-05	0.000144	CcSEcCtD
Goserelin—Shock—Topiramate—epilepsy syndrome	9.04e-05	0.000143	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—FYN—epilepsy syndrome	9.03e-05	0.000278	CbGpPWpGaD
Goserelin—Diarrhoea—Valproic Acid—epilepsy syndrome	9.02e-05	0.000143	CcSEcCtD
Goserelin—Nervous system disorder—Topiramate—epilepsy syndrome	9.02e-05	0.000143	CcSEcCtD
Goserelin—Feeling abnormal—Gabapentin—epilepsy syndrome	9e-05	0.000142	CcSEcCtD
Goserelin—Thrombocytopenia—Topiramate—epilepsy syndrome	9e-05	0.000142	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—H2AFX—epilepsy syndrome	8.99e-05	0.000277	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MEF2C—epilepsy syndrome	8.98e-05	0.000277	CbGpPWpGaD
Goserelin—Tachycardia—Topiramate—epilepsy syndrome	8.97e-05	0.000142	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.94e-05	0.000275	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	8.94e-05	0.000141	CcSEcCtD
Goserelin—Skin disorder—Topiramate—epilepsy syndrome	8.93e-05	0.000141	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PTK2B—epilepsy syndrome	8.91e-05	0.000275	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TSC1—epilepsy syndrome	8.91e-05	0.000275	CbGpPWpGaD
Goserelin—Hyperhidrosis—Topiramate—epilepsy syndrome	8.89e-05	0.00014	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AGT—epilepsy syndrome	8.78e-05	0.000271	CbGpPWpGaD
Goserelin—Hypersensitivity—Pregabalin—epilepsy syndrome	8.78e-05	0.000139	CcSEcCtD
Goserelin—Anorexia—Topiramate—epilepsy syndrome	8.76e-05	0.000139	CcSEcCtD
Goserelin—Dizziness—Valproic Acid—epilepsy syndrome	8.72e-05	0.000138	CcSEcCtD
Goserelin—Urticaria—Gabapentin—epilepsy syndrome	8.68e-05	0.000137	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—YWHAZ—epilepsy syndrome	8.68e-05	0.000267	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SST—epilepsy syndrome	8.67e-05	0.000267	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR2—epilepsy syndrome	8.67e-05	0.000267	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NTRK2—epilepsy syndrome	8.67e-05	0.000267	CbGpPWpGaD
Goserelin—Abdominal pain—Gabapentin—epilepsy syndrome	8.64e-05	0.000137	CcSEcCtD
Goserelin—Body temperature increased—Gabapentin—epilepsy syndrome	8.64e-05	0.000137	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—DUSP6—epilepsy syndrome	8.6e-05	0.000265	CbGpPWpGaD
Goserelin—Hypotension—Topiramate—epilepsy syndrome	8.59e-05	0.000136	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NGF—epilepsy syndrome	8.58e-05	0.000264	CbGpPWpGaD
Goserelin—Asthenia—Pregabalin—epilepsy syndrome	8.55e-05	0.000135	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADRA2A—epilepsy syndrome	8.49e-05	0.000262	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLAT—epilepsy syndrome	8.45e-05	0.00026	CbGpPWpGaD
Goserelin—Pruritus—Pregabalin—epilepsy syndrome	8.43e-05	0.000133	CcSEcCtD
Goserelin—Vomiting—Valproic Acid—epilepsy syndrome	8.38e-05	0.000132	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	8.38e-05	0.000132	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCR5—epilepsy syndrome	8.35e-05	0.000257	CbGpPWpGaD
Goserelin—Insomnia—Topiramate—epilepsy syndrome	8.31e-05	0.000131	CcSEcCtD
Goserelin—Rash—Valproic Acid—epilepsy syndrome	8.31e-05	0.000131	CcSEcCtD
Goserelin—Dermatitis—Valproic Acid—epilepsy syndrome	8.3e-05	0.000131	CcSEcCtD
Goserelin—Headache—Valproic Acid—epilepsy syndrome	8.26e-05	0.000131	CcSEcCtD
Goserelin—Paraesthesia—Topiramate—epilepsy syndrome	8.25e-05	0.00013	CcSEcCtD
Goserelin—Dyspnoea—Topiramate—epilepsy syndrome	8.2e-05	0.00013	CcSEcCtD
Goserelin—Somnolence—Topiramate—epilepsy syndrome	8.17e-05	0.000129	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HTR2A—epilepsy syndrome	8.17e-05	0.000252	CbGpPWpGaD
Goserelin—Diarrhoea—Pregabalin—epilepsy syndrome	8.15e-05	0.000129	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CXCL12—epilepsy syndrome	8.15e-05	0.000251	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BDKRB2—epilepsy syndrome	8.15e-05	0.000251	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—POMC—epilepsy syndrome	8.14e-05	0.000251	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCB—epilepsy syndrome	8.12e-05	0.00025	CbGpPWpGaD
Goserelin—Dyspepsia—Topiramate—epilepsy syndrome	8.09e-05	0.000128	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL6ST—epilepsy syndrome	8.08e-05	0.000249	CbGpPWpGaD
Goserelin—Hypersensitivity—Gabapentin—epilepsy syndrome	8.05e-05	0.000127	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—JUNB—epilepsy syndrome	8e-05	0.000247	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CNR1—epilepsy syndrome	8e-05	0.000247	CbGpPWpGaD
Goserelin—Decreased appetite—Topiramate—epilepsy syndrome	7.99e-05	0.000126	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PLCB1—epilepsy syndrome	7.97e-05	0.000246	CbGpPWpGaD
Goserelin—Fatigue—Topiramate—epilepsy syndrome	7.93e-05	0.000125	CcSEcCtD
Goserelin—Dizziness—Pregabalin—epilepsy syndrome	7.88e-05	0.000125	CcSEcCtD
Goserelin—Pain—Topiramate—epilepsy syndrome	7.86e-05	0.000124	CcSEcCtD
Goserelin—Constipation—Topiramate—epilepsy syndrome	7.86e-05	0.000124	CcSEcCtD
Goserelin—Asthenia—Gabapentin—epilepsy syndrome	7.84e-05	0.000124	CcSEcCtD
Goserelin—Nausea—Valproic Acid—epilepsy syndrome	7.83e-05	0.000124	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HTR7—epilepsy syndrome	7.81e-05	0.000241	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TSC2—epilepsy syndrome	7.76e-05	0.000239	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGT—epilepsy syndrome	7.75e-05	0.000239	CbGpPWpGaD
Goserelin—Pruritus—Gabapentin—epilepsy syndrome	7.73e-05	0.000122	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOE—epilepsy syndrome	7.59e-05	0.000234	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HBEGF—epilepsy syndrome	7.58e-05	0.000234	CbGpPWpGaD
Goserelin—Vomiting—Pregabalin—epilepsy syndrome	7.58e-05	0.00012	CcSEcCtD
Goserelin—Feeling abnormal—Topiramate—epilepsy syndrome	7.58e-05	0.00012	CcSEcCtD
Goserelin—Gastrointestinal pain—Topiramate—epilepsy syndrome	7.52e-05	0.000119	CcSEcCtD
Goserelin—Rash—Pregabalin—epilepsy syndrome	7.51e-05	0.000119	CcSEcCtD
Goserelin—Dermatitis—Pregabalin—epilepsy syndrome	7.51e-05	0.000119	CcSEcCtD
Goserelin—Diarrhoea—Gabapentin—epilepsy syndrome	7.48e-05	0.000118	CcSEcCtD
Goserelin—Headache—Pregabalin—epilepsy syndrome	7.47e-05	0.000118	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—KDR—epilepsy syndrome	7.44e-05	0.000229	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT3—epilepsy syndrome	7.44e-05	0.000229	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—POMC—epilepsy syndrome	7.39e-05	0.000228	CbGpPWpGaD
Goserelin—Urticaria—Topiramate—epilepsy syndrome	7.3e-05	0.000115	CcSEcCtD
Goserelin—Abdominal pain—Topiramate—epilepsy syndrome	7.27e-05	0.000115	CcSEcCtD
Goserelin—Body temperature increased—Topiramate—epilepsy syndrome	7.27e-05	0.000115	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADAM10—epilepsy syndrome	7.27e-05	0.000224	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL2—epilepsy syndrome	7.23e-05	0.000223	CbGpPWpGaD
Goserelin—Dizziness—Gabapentin—epilepsy syndrome	7.23e-05	0.000114	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PRKCB—epilepsy syndrome	7.16e-05	0.000221	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6ST—epilepsy syndrome	7.13e-05	0.00022	CbGpPWpGaD
Goserelin—Nausea—Pregabalin—epilepsy syndrome	7.08e-05	0.000112	CcSEcCtD
Goserelin—Vomiting—Gabapentin—epilepsy syndrome	6.95e-05	0.00011	CcSEcCtD
Goserelin—Rash—Gabapentin—epilepsy syndrome	6.89e-05	0.000109	CcSEcCtD
Goserelin—Dermatitis—Gabapentin—epilepsy syndrome	6.88e-05	0.000109	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—S100B—epilepsy syndrome	6.87e-05	0.000212	CbGpPWpGaD
Goserelin—Headache—Gabapentin—epilepsy syndrome	6.85e-05	0.000108	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SOCS3—epilepsy syndrome	6.8e-05	0.00021	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDC42—epilepsy syndrome	6.79e-05	0.000209	CbGpPWpGaD
Goserelin—Hypersensitivity—Topiramate—epilepsy syndrome	6.77e-05	0.000107	CcSEcCtD
Goserelin—Asthenia—Topiramate—epilepsy syndrome	6.6e-05	0.000104	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AVP—epilepsy syndrome	6.57e-05	0.000203	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—POMC—epilepsy syndrome	6.52e-05	0.000201	CbGpPWpGaD
Goserelin—Pruritus—Topiramate—epilepsy syndrome	6.5e-05	0.000103	CcSEcCtD
Goserelin—Nausea—Gabapentin—epilepsy syndrome	6.49e-05	0.000103	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCL2—epilepsy syndrome	6.38e-05	0.000197	CbGpPWpGaD
Goserelin—Diarrhoea—Topiramate—epilepsy syndrome	6.29e-05	9.94e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HES1—epilepsy syndrome	6.21e-05	0.000192	CbGpPWpGaD
Goserelin—Dizziness—Topiramate—epilepsy syndrome	6.08e-05	9.61e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FYN—epilepsy syndrome	6.04e-05	0.000186	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—H2AFX—epilepsy syndrome	6.02e-05	0.000186	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MEF2C—epilepsy syndrome	6.01e-05	0.000185	CbGpPWpGaD
Goserelin—Vomiting—Topiramate—epilepsy syndrome	5.84e-05	9.24e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—YWHAZ—epilepsy syndrome	5.81e-05	0.000179	CbGpPWpGaD
Goserelin—Rash—Topiramate—epilepsy syndrome	5.8e-05	9.16e-05	CcSEcCtD
Goserelin—Dermatitis—Topiramate—epilepsy syndrome	5.79e-05	9.15e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—FGF2—epilepsy syndrome	5.77e-05	0.000178	CbGpPWpGaD
Goserelin—Headache—Topiramate—epilepsy syndrome	5.76e-05	9.1e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NGF—epilepsy syndrome	5.74e-05	0.000177	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR5—epilepsy syndrome	5.59e-05	0.000172	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR2A—epilepsy syndrome	5.47e-05	0.000169	CbGpPWpGaD
Goserelin—Nausea—Topiramate—epilepsy syndrome	5.46e-05	8.63e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RELA—epilepsy syndrome	5.36e-05	0.000165	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MTOR—epilepsy syndrome	5.25e-05	0.000162	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TSC2—epilepsy syndrome	5.19e-05	0.00016	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGT—epilepsy syndrome	5.19e-05	0.00016	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOE—epilepsy syndrome	5.08e-05	0.000157	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KDR—epilepsy syndrome	4.98e-05	0.000153	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—epilepsy syndrome	4.88e-05	0.00015	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASP3—epilepsy syndrome	4.83e-05	0.000149	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCB—epilepsy syndrome	4.79e-05	0.000148	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6ST—epilepsy syndrome	4.77e-05	0.000147	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JUN—epilepsy syndrome	4.69e-05	0.000145	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—epilepsy syndrome	4.56e-05	0.000141	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—epilepsy syndrome	4.43e-05	0.000136	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—POMC—epilepsy syndrome	4.37e-05	0.000135	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—epilepsy syndrome	4.27e-05	0.000132	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SRC—epilepsy syndrome	4.21e-05	0.00013	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—epilepsy syndrome	4.1e-05	0.000126	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGF2—epilepsy syndrome	3.86e-05	0.000119	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RELA—epilepsy syndrome	3.58e-05	0.00011	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MTOR—epilepsy syndrome	3.52e-05	0.000108	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—epilepsy syndrome	3.26e-05	0.000101	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP3—epilepsy syndrome	3.23e-05	9.97e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JUN—epilepsy syndrome	3.14e-05	9.68e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—epilepsy syndrome	3.06e-05	9.42e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—epilepsy syndrome	2.96e-05	9.13e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SRC—epilepsy syndrome	2.82e-05	8.68e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—epilepsy syndrome	2.74e-05	8.46e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—epilepsy syndrome	2.62e-05	8.06e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—epilepsy syndrome	1.75e-05	5.4e-05	CbGpPWpGaD
